Fisetin-loaded nanoemulsion ameliorates lung cancer pathogenesis via downregulating cathepsin-B, galectin-3 and enolase in an in vitro setting

EXCLI J. 2024 Oct 14:23:1238-1244. doi: 10.17179/excli2024-7583. eCollection 2024.

Ayeh Bani Saeid^{1

2}, Keshav Raj Paudel³, Gabriele De Rubis^{1

2}, Samir Mehndiratta¹, Sofia Kokkinis^{1

2}, Sukriti Vishwas⁴, Stewart Yeung^{1

2}, Gaurav Gupta^{5

6}, Sachin Kumar Singh^{2

4}, Kamal Dua^{1

2}

¹ Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia.
² Faculty of Health, Australian Research Center in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, 2007, Australia.
³ Center for Inflammation, Faculty of Science, School of Life Sciences, Centenary Institute and University of Technology Sydney, Sydney, NSW, 2007, Australia.
⁴ School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, 144411, India.
⁵ Center for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Punjab, India.
⁶ Center of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.

No abstract available